CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) |
Total |
Series B Warrant |
Common Stock Warrants |
Prefunded Warrants |
Common Stock |
Common Stock
Series B Warrant
|
Common Stock
Common Stock Warrants
|
Common Stock
Prefunded Warrants
|
Additional Paid-In Capital |
Additional Paid-In Capital
Series B Warrant
|
Additional Paid-In Capital
Common Stock Warrants
|
Accumulated Deficit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beginning balance (in shares) at Dec. 31, 2019 | 182,895,247 | |||||||||||
| Beginning balance at Dec. 31, 2019 | $ 548,058 | $ 182,895 | $ 32,538,445 | $ (32,173,282) | ||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||
| Stock-based compensation expense | 64,142 | 64,142 | ||||||||||
| Warrant exercise (in shares) | 312,500 | |||||||||||
| Warrant exercise | $ 26,563 | $ 313 | $ 26,250 | |||||||||
| Net loss | (2,341,660) | (2,341,660) | ||||||||||
| Ending balance (in shares) at Mar. 31, 2020 | 183,207,747 | |||||||||||
| Ending balance at Mar. 31, 2020 | (1,702,897) | $ 183,208 | 32,628,837 | (34,514,942) | ||||||||
| Beginning balance (in shares) at Dec. 31, 2020 | 288,074,415 | |||||||||||
| Beginning balance at Dec. 31, 2020 | 450,786 | $ 288,074 | 38,896,693 | (38,733,981) | ||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||
| Stock-based compensation expense (in shares) | 600,000 | |||||||||||
| Stock-based compensation expense | 146,580 | $ 600 | 145,980 | |||||||||
| Warrant exercise (in shares) | 11,800,000 | 67,166,667 | 11,800,000 | |||||||||
| Warrant exercise | $ 4,030,000 | $ 11,800 | $ 67,167 | $ 11,800 | $ 3,962,833 | |||||||
| Net loss | (2,160,517) | (2,160,517) | ||||||||||
| Ending balance (in shares) at Mar. 31, 2021 | 367,641,082 | |||||||||||
| Ending balance at Mar. 31, 2021 | $ 2,478,649 | $ 367,641 | $ 43,005,506 | $ (40,894,498) |
| X | ||||||||||
- Definition Stock Issued During Period, Shares, Warrant Exercises No definition available.
|
| X | ||||||||||
- Definition Stock Issued During Period, Value, Warrant Exercises No definition available.
|
| X | ||||||||||
- Definition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|